BridgeMD
New treatment option for Breast Cancer
Official title Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer
ClinicalTrials.gov ID: NCT06772935
What this study is testing
- What it's testing
- Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Breast cancer patients diagnosed by pathology;
- EOOG score is 0 or 1;
- The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination); ⑤...
- Accept regular follow-up visits; ⑨ There is complete pathological data available.
You likely can't join if
- Non breast cancer patients;
- Received electroacupuncture treatment within 6 months prior to the start of the study;
- Patients who experience intolerable toxic side effects during standard dose chemotherapy and terminate the chemotherapy cycle;
- Prior to enrollment, there was a history of peripheral neuropathy;
- Unstable heart disease or myocardial infarction within the first 6 months of the study; ⑥ Active skin diseases or surface skin ulcers or infections...
The study team makes the final eligibility decision.
Where it's taking place
- Xining, Qinghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xining, Qinghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.